1. Gao, X, Scott, W K, Wang, G, Vance, J M, Martin, E R. 2008. Gene-gene interaction between FGF20 and MAOB in Parkinson disease. In Annals of human genetics, 72, 157-62. doi:10.1111/j.1469-1809.2007.00418.x. https://pubmed.ncbi.nlm.nih.gov/18205889/
2. Zhao, Xianjing, Wu, Yanfeng, Zhao, Can, Feng, Meijiang. 2016. Association between FGF20 rs12720208 gene polymorphism and Parkinson's disease: a meta-analysis. In Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 37, 1119-26. doi:10.1007/s10072-016-2559-0. https://pubmed.ncbi.nlm.nih.gov/27023076/
3. Katoh, Masaru. 2016. FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review). In International journal of molecular medicine, 38, 3-15. doi:10.3892/ijmm.2016.2620. https://pubmed.ncbi.nlm.nih.gov/27245147/
4. Elo, Teresa, Lindfors, Päivi H, Lan, Qiang, Howard, Beatrice A, Mikkola, Marja L. 2017. Ectodysplasin target gene Fgf20 regulates mammary bud growth and ductal invasion and branching during puberty. In Scientific reports, 7, 5049. doi:10.1038/s41598-017-04637-1. https://pubmed.ncbi.nlm.nih.gov/28698625/
5. Zhu, Ruixia, Zhu, Ying, Liu, Xu, He, Zhiyi. 2014. Fibroblast growth factor 20 (FGF20) gene polymorphism and risk of Parkinson's disease: a meta-analysis. In Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 35, 1889-94. doi:10.1007/s10072-014-1853-y. https://pubmed.ncbi.nlm.nih.gov/24942208/
6. Jiménez, Karen M, Pereira-Morales, Angela J, Adan, Ana, Lopez-Leon, Sandra, Forero, Diego A. 2018. Depressive symptoms are associated with a functional polymorphism in a miR-433 binding site in the FGF20 gene. In Molecular brain, 11, 53. doi:10.1186/s13041-018-0397-0. https://pubmed.ncbi.nlm.nih.gov/30241547/
智鼠故事 
